Guided Therapeutics Inc
OTC:GTHP

Watchlist Manager
Guided Therapeutics Inc Logo
Guided Therapeutics Inc
OTC:GTHP
Watchlist
Price: 0.5 USD -7.41% Market Closed
Market Cap: 41.8m USD

EV/EBITDA
Enterprise Value to EBITDA

-18.1
Current
-4
Median
11.9
Industry
Lower than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-18.1
=
Enterprise Value
40.9m USD
/
EBITDA
-2.3m USD
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
N/A
2-Years Forward
EV/EBITDA
N/A
3-Years Forward
EV/EBITDA
N/A